18+ · Research Use Only · Not for Human Consumption
Research answer
Is there human research on BPC-157?
Very little. As of 23 September 2026, the human research on BPC-157 is two small uncontrolled reports, in interstitial cystitis and knee pain, with no randomised placebo-controlled trial found. Almost everything else is rat and cell work on tendon, ligament, muscle and gut injury, so the Research Desk rates it small human studies.
Primara Labs sells some of the compounds covered here. Every figure on this page links to its source and the date it was checked.
Updated 23 September 2026
01
The two human reports
In an uncontrolled pilot of 12 women with interstitial cystitis, 10 reported complete symptom resolution; there was no placebo or comparison group.
In a retrospective phone survey of 16 clinic patients, 14 reported knee pain relief; there was no control group and no validated outcome measure.
02
The animal work behind it
In rats with a cut Achilles tendon, BPC-157 improved mechanical, functional and microscopic healing measures compared with saline. This is a rat study, and results in rats do not establish effects in people.
In rats with a surgically cut knee ligament, BPC-157 improved functional, mechanical and tissue measures of healing over 90 days. Also in rats.
BPC-157 is a synthetic 15-amino-acid peptide. A 2025 systematic review summarises animal and cell studies as showing raised growth hormone receptor expression, activation of pathways for cell growth and new blood vessel formation, and lower inflammatory signalling. No receptor has been identified, and the same review notes it is broken down quickly in the liver. None of these mechanisms has been shown in people.
03
Safety data
The two small uncontrolled pilots, of 2 and 12 people, reported no adverse events. A 2025 systematic review states that no clinical safety data were found.
No randomised controlled human trial of BPC-157 was found in the Europe PMC search the Research Desk ran.
04
What a stronger study would look like
The step that would change BPC-157's evidence level is a randomised trial with a placebo or comparison group, a named outcome measured the same way in both groups, and adverse events recorded by arm. None has been published.
Sources
Where every figure comes from
- PubMed 39325560 · checked 23 September 2026
- PubMed 34324435 · checked 23 September 2026
- J Orthop Res 2003 · checked 23 September 2026
- HSS J 2025 (systematic review) · checked 23 September 2026
Last reviewed 23 September 2026